|
Granulocyte-macrophage colony stimulating factor improves flu survival in mice. |
 |
 |
|
EurekAlert: New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus. While GM-SCF therapy for humans as a flu prophylaxis or treatment may be years away, the study results were striking: All of the mice treated with GM-SCF survived after being infected with the influenza virus, whereas untreated mice all died from the same infection.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
